Translating ECHOS2 Into an mHealth Platform

Evaluation of Cardiovascular Health Outcomes Among Survivors 2 (ECHOS2) Pilot Intervention: Translating ECHOS Into an mHealth Platform

Childhood cancer survivors are at an increased risk of cardiac toxicity due to prior anti-cancer therapy. However, adherence to cardiac screening in this population remains low. This study aims to assess the feasibility of an mHealth motivational interviewing platform called Computerized Authoring Intervention Software (CIAS) in childhood cancer survivors. Participants will be recruited from the Childhood Cancer Survivorship Study.

Inclusion Criteria:

• 18 years of age or older
• Diagnosed with cancer at age 17 or younger
• 2 or more years after completion of cancer therapy
• Receipt of cardiotoxic therapy (Any dose of anthracycline or 15 Gy chest radiation involving cardiac structures)
• No history of cardiomyopathy
• Have not received an echocardiogram in the past 5 years